Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prospects for hepatitis C vaccine.

G M Bhopale1, R K Nanda

  • 1Research and Development Division, Hindustan Antibiotics Ltd., Pimpri, Pune 411018, India. girishbhopale@rediffmail.com

Acta Virologica
|March 5, 2005
PubMed
Summary

Developing an effective Hepatitis C virus (HCV) vaccine is crucial due to the lack of current therapies. This review explores promising vaccine strategies to combat HCV infection and its severe liver complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simultaneous estimation of Montelukast sodium and Bambuterol hydrochloride in tablets by spectrophotometry.

Hindustan antibiotics bulletin·2009
Same author

ELISA using enzyme penicillinase for the detection of IgG antibodies to Trypanosoma evansi in sera of experimentally infected rabbits.

Hindustan antibiotics bulletin·2006
Same author

Dr. M.J. Thirumalachar, (1914-1999)- an obituary and bibliography.

Hindustan antibiotics bulletin·2004
Same author

Blood coagulation factor VIII: An overview.

Journal of biosciences·2003
Same author

Pathogenesis of toxoplasmosis.

Comparative immunology, microbiology and infectious diseases·2003
Same author

Detection of circulating antigens by ELISA using penicillinase in sera of mice infected with Toxoplasma gondii.

Roczniki Akademii Medycznej w Bialymstoku (1995)·2001

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV) is a significant global cause of chronic liver disease, cirrhosis, and liver cancer.
  • Currently, no effective vaccine or curative therapy exists for HCV infection.
  • Understanding the immune response to HCV is vital for vaccine development.

Purpose of the Study:

  • To review the characteristics of an effective vaccine for controlling HCV infection.
  • To discuss the challenges and promising approaches in HCV vaccine development.

Main Methods:

  • Review of existing literature on HCV pathogenesis and vaccine research.
  • Summary of various vaccine platforms and their potential for HCV.

Main Results:

  • Humoral and cellular immune responses are presumed to be important for protection against HCV.
  • Several promising vaccine strategies are being investigated, including DNA, recombinant virus, HCV-like particles (HCV-LPs), peptide-based, and plant-derived subunit vaccines.

Conclusions:

  • Despite obstacles, diverse vaccine approaches show potential for controlling HCV infection.
  • Further research into immune mechanisms and vaccine technologies is necessary for an effective HCV vaccine.

Related Experiment Videos